Pierre: Thanks for having me, Spiffy! At InGel, we are creating novel cell therapies and tissue engineering solutions to treat patients affected by blinding disease, also known as retinal degenerative diseases. Most of these patients have no treatment and dread the day when the last ray of light will enter their eyes and they will wake up permanently blind. Our mission is to bring back light to these patients using our innovation. Our technology is gene agnostic, has shown tremendous pre-clinical efficacy and safety, and can be used to treat many different indications, such as Retinitis Pigmentosa and Dry-AMD.
Dallas: Thanks for having me, Spiffy! Birth control is often misprescribed. This leads to a grueling trial and error process where 75% of people describe their experience with birth control negatively. It’s also extremely time consuming, taking an average of two years for someone to find a method that they like. Not to mention, this trial and error is harmful to a person’s wellbeing. Reya provides personalized and collaborative reproductive and sexual health care and support for people with ovaries globally.
Alex: Thanks for having me, Spiffy! As CEO of a 1,500-staff hospitality company, I struggled to retain people with us for longer. We were bleeding over 500 employees a year which was costing us over one million euros per year. I initially faced low morale, and a difficulty to attract quality people, as well as develop our high potentials. I tested out many ideas to improve engagement, productivity, and retention, which resulted in halving our attrition rate and saving hundreds of thousands that we then invested back in delivering an exceptional employee experience. Moonstar was built out of my challenge of finding a far-reaching solution to help mid-sized companies invest in their employees to build a highly productive, connected, and happier workforce.
